Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Brian Acker, CA
King PharmaceuticalsKGPAST TOP PICKSep 25, 2003
(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
Brian Acker, CAOwned
$15.25
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Has great value. US Healthcare looks very inexpensive.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
Will be volatile. An OK company at a bargain price. Good risk/reward.
Peter Arender, CFAOwned
biotechnologypharmaceutical
TOP PICK
(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
Brian Acker, CAOwned
biotechnologypharmaceutical
